Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
"An open-label extension study of the long-term safety, tolerability and efficacy of Ambrisentan in subjects with inoperable chronic thromboembolic pulmonary hypertension(CTEPH)."	GSK	Completed	Ambrisentan	3	116457	KFMC
AN OPEN LABEL, SINGLE ARM, MULTICENTER,SAFETY STUDY OF ATEZOLIZUMAB IN LOCALLY ADVANCED OR METASTATIC UROTHELIAL OR NON-UROTHELIAL CARCINOMA OF THE URINARY TRACT	Roche	Completed	Atezolizumab (MPDL3280A; RO5541267)	3	MO29983	KFSH & RC-R
An Open Label, Multicenter, Dose Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of SBC-102 (Sebelipase Alfa) in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency	Synageva	Completed	Sebelipase alfa (SBC-102)	2	LAL-CL03	KFSH & RC-R
"An International, Double-blind, Randomised, Placebo-Controlled Phase III Study to Evaluate the Effect of Dapagliflozin on Reducing CV Death or Worsening Heart Failure in Patients with Heart Failure with Preserved Ejection Fraction (HFpEF) DELIVER - Dapagliflozin Evaluation to Improve the LIVEs of Patients with PReserved Ejection Fraction Heart Failure "	AstraZeneca	Ongoing	Dapagliflozin	3	D169CC00001	KKUH
An international randomised trial of additional treatments for COVID-19 in hospitalised patients who are all receiving the local standard of care	GDRS (MOH)	Ongoing	Hydroxychloroquine sulphate	3	version 8	QCH
"ALL SCTped 2012 FORUM Allogeneic Stem Cell Transplantation in Children and Adolescents with Acute Lymphoblastic Leukaemia"	KAIMRC	Ongoing	BUSULFAN	3	CT17/016/R	NGHA-R
Adjunct Low Dose Ketamine Infusion Versus Standard of Care in Mechanically Ventilated Critically Ill Patients at a Tertiary Saudi Hospital (ATTAINMENT Trial): Randomized, Prospective, Pilot Trial	King Faisal Specialist Hospital and Research Centre	Ongoing	Ketamine	3	2191187	KFSH & RC-R
A two part seamless, open label, multi-center study to investigate the safety, tolerability, pharmacokinetics, pharmacodynamics and efficacy of RO7034067 in infants with type 1 spinal muscular atrophy.	Roche	Ongoing	RO7034067	2	BP39056	KFSH&RC-R
A Trial of Favipiravir in Adults with Mild Coronavirus Disease Covid-19	KAIMRC	Ongoing	Favipiravir	3	RC20/220/R	NGHA-R
A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19	KAIMRC	Terminated	Favipiravir	3	RC20/174/R	NGHA-R